Resistance to Third-Generation Cephalosporins and Other Antibiotics by Enterobacteriaceae in Western Nigeria

被引:7
|
作者
Okesola, A. O. [1 ]
Makanjuola, O. [1 ]
机构
[1] Univ Ibadan, Univ Coll Hosp, Coll Med, Dept Med Microbiol & Parasitol, Ibadan, Nigeria
关键词
Enterobacteriaceae; third-generation cephalosporins; resistance;
D O I
10.3844/ajidsp.2009.17.20
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Problem statement: The emergence and spread of resistance to third-generation cephalosporins are threatening to create species resistant to all currently available agents. The most common cause of bacterial resistance to beta-lactam antibiotics is the production of beta-lactamases and many of the 2nd and 3rd-generation penicillins and cephalosporins were specifically designed to resist the hydrolytic action of major beta-lactamases. However new beta-lactamases emerged against each of the new classes of beta-lactams that were introduced and caused resistance. This study was designed to determine the rate of resistance to 3rd-generation cephalosporins and other classes of antibiotics by the Enterobacteriaceae in this environment. Approach: One hundred bacteria isolates belonging to the family Enterobacteriaceae identified from different clinical specimens between October and December 2007 using standard bacteriological methods. These were subjected to antibiotic susceptibility testing to third-generation cephalosporins and other classes of antibiotics which included quinolones and an aminoglycoside using the Kirby-Bauer method of disc diffusion test. Results: Out of the total number of Enterobacteriaceae isolated in the study period, only 54.8% of the klebsiella species isolated were sensitive to ceftazidime, 48.4% to ceftriaxone and 30.7% to cefotaxime. With Escherichia coli however, the susceptibility pattern to the 3rd-generation cephalosporins was better (65.6% were sensitive to ceftazidime, 62.5% to ceftriaxone and 71.9% to cefotaxime). In proteus species, the susceptibility pattern was generally poor to the three classes of antibiotics(50% were sensitive to ceftazidime and ceftriaxone, 0% to cefotaxime, 33.3% to ciprofloxacin, 50% to gentamycin and 0% to amoxycillin/clavulanate). Conclusion/Recommendations: The poor susceptibility to amoxicillin/clavulanate demonstrated by all the isolates in this study showed the probability of new beta-lactamases production. Further studies therefore need to be done in this environment to determine the types of the beta-lactamases produced by the Enterobacteriaceae here, the prevalent rate of such isolates and the molecular analysis of the new beta-lactamases produced.
引用
收藏
页码:17 / 20
页数:4
相关论文
共 50 条
  • [31] A Waterborne Outbreak of Shigella sonnei with Resistance to Azithromycin and Third-Generation Cephalosporins in China in 2015
    Ma, Qiuxia
    Xu, Xuebin
    Luo, Ming
    Wang, Jian
    Yang, Chaojie
    Hu, Xiaofeng
    Liang, Beibei
    Wu, Fuli
    Yang, Xiaoxia
    Wang, Jinyan
    Liu, Hongbo
    Li, Wen
    Zhong, Yu
    Li, Peng
    Xie, Jing
    Jia, Leili
    Wang, Ligui
    Hao, Rongzhang
    Du, Xinying
    Qiu, Shaofu
    Song, Hongbin
    Sun, Yansong
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (06)
  • [32] Evaluation of the BL-RED (Beta-Lactamase Rapid Electrochemical Detection) test for the rapid detection of resistance to third-generation cephalosporins in Enterobacteriaceae
    Ben Abdallah, Ziad
    Tamisier, Norbert
    Lleres-Vadeboin, Manon
    Grattard, Florence
    Pozzetto, Bruno
    Verhoeven, Paul O.
    Carricajo, Anne
    JOURNAL OF MICROBIOLOGICAL METHODS, 2022, 203
  • [33] High rates of antimicrobial co-resistance among Enterobacteriaceae:: comparative analysis between clinical isolates resistant and susceptible to third-generation cephalosporins
    Goyanes, M. J.
    Cercenado, E.
    Insa, R.
    Morente, A.
    Alcala, L.
    Bouza, E.
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2007, 20 (02) : 216 - 221
  • [34] Third-Generation Cephalosporin-Resistant Enterobacteriaceae in Africa
    Asogwa, Ifunanya E.
    ARCHIVES OF PHARMACY PRACTICE, 2018, 9 (01) : 1 - 2
  • [35] Use of broad-spectrum antibiotics in French EDs: different trends for third-generation cephalosporins and fluoroquinolones
    Batard, Eric
    Vibet, Marie-Anne
    Lemarchand, Cathelle
    Navas, Dominique
    Lepelletier, Didier
    Potel, Gilles
    Montassier, Emmanuel
    EUROPEAN JOURNAL OF EMERGENCY MEDICINE, 2017, 24 (03) : 189 - 195
  • [36] Frequency and epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae isolates susceptible to third-generation cephalosporins or to aztreonam
    Bert, F.
    Bialek-Davenet, S.
    Leflon-Guibout, V.
    Noussair, L.
    Nicolas-Chanoine, M. -H.
    MEDECINE ET MALADIES INFECTIEUSES, 2014, 44 (02): : 76 - 78
  • [37] Infections caused by naturally AmpC-producing Enterobacteriaceae: Can we use third-generation cephalosporins? A narrative review
    Mizrahi, A.
    Delerue, T.
    Morel, H.
    Le Monnier, A.
    Carbonnelle, E.
    Pilmis, B.
    Zahar, J. R.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (02)
  • [38] Investigation of the mechanism of resistance to third-generation cephalosporins by class C β-lactamases by using chemical complementation
    Carter, BT
    Lin, HN
    Goldberg, SD
    Althoff, EA
    Raushel, J
    Cornish, VW
    CHEMBIOCHEM, 2005, 6 (11) : 2055 - 2067
  • [39] Escherichia coli: placing resistance to third-generation cephalosporins and fluoroquinolones in Australia and New Zealand into perspective
    White, Rhys T.
    MICROBIOLOGY AUSTRALIA, 2021, 42 (03) : 104 - 110
  • [40] Third-generation cephalosporins for upper respiratory tract infections - Reply
    不详
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2002, 92 (10): : 746 - 746